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Ca2+ signaling plays a central role in activity-
dependent regulation of dendritic arborization,
but key molecular mechanisms downstream of
calcium elevation remain poorly understood.
Here we show that the C-terminal region of
the Ca2+/calmodulin-dependent protein kinase
CLICK-III (CL3)/CaMKIg, amembrane-anchored
CaMK,was uniquelymodified by two sequential
lipidification steps: prenylation followed by a
kinase-activity-regulated palmitoylation. These
modifications were essential for CL3membrane
anchoring and targeting into detergent-
resistant lipid microdomains (or rafts) in the
dendrites. We found that CL3 critically contrib-
uted to BDNF-stimulated dendritic growth.
Raft insertion of CL3 specifically promoted
dendritogenesis of cortical neurons by acting
upstream of RacGEF STEF and Rac, both pres-
ent in lipid rafts. Thus, CL3 may represent a key
element in the Ca2+-dependent and lipid-raft-
delineated switch that turns on extrinsic
activity-regulated dendrite formation in devel-
oping cortical neurons.
INTRODUCTION
Neurons grow two characteristic processes: axons and
dendrites. The specification of these processes, their
outgrowth, and their precise arborization are prerequisites
for the formation of appropriate connections between
neurons. These steps, which constitute the basis for theestablishment of neuronal circuits, represent central
questions in neuroscience for which the molecular mech-
anisms still remain largely unsolved.
The dendrite formation, which is critical for proper
integration of synaptic inputs, is believed to be determined
by genetically encoded cell-intrinsic signals as well as
environmental-extrinsic signals from neighboring cells.
Recent works have shed light on the critical roles of sem-
aphorin 3A, neurotrophins, Notch1, Slit-1, cadherin, BMP,
and Wnt/b-catenin in mediating signaling events regulat-
ing various stages of dendritogenesis in the developing
cerebral cortex (reviewed in Ciani and Salinas, 2005;
Higgins et al., 1997; Jan and Jan, 2003; Whitford et al.,
2002). In addition, a wealth of work has shown that the for-
mation of dendritic trees is shaped by neuronal activity
(Cline, 2001; Konur and Ghosh, 2005). For example, surgi-
cal and pharmacological attenuation of sensory inputs
impaired dendritic development in the visual cortex as
well as in the barrel cortex (Fox and Wong, 2005), while
in contrast, enriched environments promoted dendritic
growth (Kozorovitskiy et al., 2005). However, how neural
activity regulates dendrite arborization at the molecular
and cellular level is not well understood.
Activity-dependent regulation of dendritic arbors is
believed to be mediated, in large part, via increases in
intracellular calcium concentration, which in turn activate
several signaling cascades. How can neuronal activity
influence dendrite formation downstream of calcium entry
and mobilization? Several works have so far indicated
a possible involvement of one or multiple members of
the multifunctional Ca2+/calmodulin (CaM)-dependent
protein kinases (CaMKs) family in dendritic development.
CaMKs represent major targets for an activated Ca2+/
CaM complex generated by intracellular calcium rise,
and two subclasses (the CaMKI/IV subfamily [consistingNeuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc. 755
Neuron
Regulation of Dendritogenesis via CLICK-III/CaMKIgof five genes] and a CaMKII subfamily [consisting of four
genes]) have been shown to be highly expressed in the
central nervous system (CNS) (Soderling and Stull, 2001;
Hook and Means, 2001; Hudmon and Schulman, 2002).
The general CaMK inhibitor KN-62, which inhibited
activation of members of both kinase subclasses, was
shown to block neurite outgrowth in various cell lines
(Zheng et al., 1994; Kuhn et al., 1998; Vaillant et al.,
2002). The role of CaMKII in neurite outgrowth has been
controversial, however, in part because of the contrasting
effect observed between the a and b isoforms of CaMKII
(Konur and Ghosh, 2005). CaMKIV, enriched in the
nucleus, was shown to mediate dendrite formation via
CREB phosphorylation and CREB-mediated transcription
(Redmond et al., 2002). Additionally, CaMKI activity may
participate in the regulation of growth cone motility and
neurite extension (Wayman et al., 2004; Schmitt et al.,
2004), but the underlying isoforms and critical mecha-
nisms involved remained obscure.
Recently, a variety of Rho small GTPase family proteins
were shown to contribute to dendritic morphogenesis
through regulation of actin cytoskeletal remodeling (Luo,
2002; Van Aelst and Cline, 2004). How the small GTPase
activity was turned on and off as a function of neuronal
activity and multiple coexisting extracellular cues
remained largely unknown. In some instances, the GDP-
GTP exchange factor (GEF) for a Rho small GTPase family
protein was shown to be activated downstream of Ca2+.
Thus, a synaptically localized Rac-GEF Tiam1 was
involved in the regulation of dendritic spines by linking
NMDA-receptor activity to Rac1-dependent actin remod-
eling (Tolias et al., 2005). However, it was not known
whether nor which specific CaMK activity may contribute
to small GTPase-dependent dendritic actin remodeling
during dendritogenesis.
Here, we show a unique function of a lipid-raft-
associated Ca2+/calmodulin-dependent protein kinase,
CLICK-III (CL3)/CaMKIg, in dendritogenesis of developing
cortical neurons. The C-terminal end of CL3 was the
substrate for sequential lipidifications, i.e., prenylation
and palmitoylation. Prenyl-palmitoyl-CL3, generated in
a kinase-activity-dependent manner, efficiently accumu-
lated into dendrite-enriched raft-like lipid microdomains.
Intriguingly, knockdown or knockout of CL3 reduced the
number and the total length of dendrites, but not those
of axons. Furthermore, blockade of CL3 occluded
BDNF-stimulated dendritic growth, and CL3 membrane
anchoring appeared to play an important role in mediating
this morphological effect. In keeping with the critical sig-
nificance of raft insertion of CL3, Rac and its upstream
regulator STEF, a Rac-specific GEF, acted downstream
of CL3 in the molecular cascade linking Ca2+ to actin
remodeling, and both were present in the lipid rafts. Con-
sistent with these results, Rac activity was sufficient to
rescue the dendritic phenotype associated with CL3
knockdown, while raft disruption abolished the dendrito-
genic effect of CL3 overexpression. Taken together, we
thus uncovered a novel CaMK-Rac signaling pathway by756 Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc.which lipid raft insertion and activation of a specific CaMKI
isoform may couple extrinsic neuronal activity with
dendrite-restricted cytoskeletal remodeling in developing
cortical neurons.
RESULTS
Prenylated CL3 Is Palmitoylated in a Kinase-Activity-
Dependent Manner and This Dual Lipidification
Determines Golgi Membrane Anchoring
and Dendrite-Enriched Lipid Raft Targeting
Prenylation was often reported to be accompanied by
palmitoylation in many neuronal proteins (El-Husseini
and Bredt, 2002). We directly tested the presence of
multiple palmitoylation sites in the vicinity of the CAAX
motif of CL3/CaMKIg, a membrane-anchored CaMK
(Takemoto-Kimura et al., 2003) (Figure 1A). Tritiated
precursors for either prenyl or palmitoyl moieties, [3H]-
mevalonate or [3H]-palmitate, were added in the culture
medium of COS-7 cells expressing either wild-type (WT)
CL3 or various C-to-S substitution mutants of CL3, and
lipidification of CL3 was tested using SDS-PAGE and
digital autoradiography. Either [3H]-mevalonate conjuga-
tion or [3H]-palmitate incorporation was significantly
detected in WT-expressing cells (Figures 1B and 1C,
WT). The former was absent in a C474Smutant (Figure 1B,
C474S), consistent with a CAAX prenylation. In contrast,
the latter was reduced to background levels in a quadruple
mutation (4CS) of four cysteines (C417S, C419S, C420S,
and C423S) (Figure 1C, 4CS), identifying these residues
as potential palmitoylation sites.
We next testedwhether there was a possible interaction
between prenylation, palmitoylation, and kinase activity.
Interestingly, the 4CS mutant was prenylated to a similar
extent as the WT CL3 (Figure 1D), while palmitoylation
was hardly detected in a prenylation-deficient C474S
mutant (Figure 1E). Thus, prenylation and palmitoylation
might take place in a series, with prenylation perhaps
occurring prior to and as a prerequisite for palmitoylation.
Furthermore, a K52A kinase-inactive mutant of CL3, in
which the consensus ATP-binding lysine residue was
replaced with an alanine, was prenylated as much as the
WT (Figure 1D), but its palmitoylation was significantly
impaired (Figure 1E). These lines of evidence suggested
that kinase activation on a prenylated (and thus presum-
ably membrane inserted) CL3 may perhaps trigger a
robust conformational change near the membranes that
is necessary for full palmitoylation.
Recently, 23 palmitoyl acyl transferases (PATs) have
been identified (Fukata et al., 2004; Linder and
Deschenes, 2004). The brain-specific localization and
the Golgi enrichment of a PAT, originally identified as
a Golgi-apparatus-specific protein with the DHHC zinc
finger domain (GODZ) (Uemura et al., 2002), were reminis-
cent of the distribution of CL3. We therefore tested
whether GODZ might palmitoylate CL3. GODZ coexpres-
sion with CL3 in heterologous cells yielded a 4.3-fold
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Is Covalently Modified by a Dual Lipidifi-
cation Mechanism that Involves Prenyla-
tion of the CAAXMotif and a Subsequent
Activity-Regulated Palmitoylation
(A) Domain structure of CL3 (upper panel) and
amino acid sequence of its C-terminal end
(lower panel). The numbers show the position
of amino acid residues. In addition to a classi-
cal prenylation site at the Cys-474 residue (in
blue) of the C-terminal CAAX motif (double
underline), the unique C-terminal region of
CL3 contained multiple Cys residues (in red
and green), which constituted potential
palmitoylation sites. Among them, four neigh-
boring Cys (in red and underlined) were
experimentally validated as critical residues
for palmitoylation, as shown also in (C). AID,
autoinhibitory domain; CBD, Ca2+/calmodulin-
binding domain.
(B) Prenylation of the CAAX motif of CL3.
Immunoprecipitates for each sample were
obtained using an anti-GFP antibody and ex-
amined by SDS-PAGE followed by autoradio-
graphic exposure. [3H]-mevalonate ([3H]-MVA)
incorporation (left) was detected in a wild-type
GFP-CL3 (WT), but not in a CAAX motif
mutant (C474S) or GFP alone. The amount
of loaded proteins in each lane was compara-
ble, as shown by CBB staining (right). The
mobility of GFP-CL3 and GFP are indicated
by arrows, and the heavy chain of the IgG
used for immunoprecipitation is shown by an
asterisk.
(C) Determination of critical palmitoylated
Cys residues on CL3. Incorporation of [3H]-
palmitate ([3H]-Pal) was observed in wild-type
GFP-CL3 (WT). Incorporation of [3H]-palmitate
was significantly diminished in twomutants (in red),C417/419/420S (tripleCys-to-Ser substitution at residues417, 419, and420) andC423S, indicating
the existence of multiple Cys residues critical for palmitoylation. Unaffected mutants are shown in green. A quadruple mutant (4CS) with a quadruple
substitution had the least amount of [3H]-palmitate incorporation and was considered to be a palmitoylation-deficient mutant (4CS).
(D)Unchanged level of prenylation onboth apalmitoylation-deficient (4CS) and a kinase-dead (K52A, a Lys residue in theATP-binding pocket replaced
with an Ala) mutant of CL3.
(E) A decrease in palmitoylation was observed in a prenylation-deficient mutant (C474S), as well as a kinase-inactive mutant (K52A).
(F) Coexpression of HA-GODZ, a neuronal palmitoyl acyl transferase, led to a significant increase in CL3 palmitoylation by 4.32 ± 0.55 fold (n = 5). **p <
0.01 by paired t test.increase (4.3 ± 0.55, n = 5) in the amount of palmitate
incorporation (Figure 1F).
We previously found that prenylation per se may be
necessary for membrane anchoring and for trafficking to
diverse membrane compartments, such as the Golgi
apparatus or the plasma membranes (Takemoto-Kimura
et al., 2003). To test whether an additional palmitoylation
may help to redistribute CL3 into specific membrane
signalosomes such as those enriched at lipid rafts (Ander-
son and Jacobson, 2002), we expressed GFP-tagged CL3
(GFP-CL3) in cultured cortical neurons using a lentiviral
vector driven by a synapsin I promoter. Consistent with
our hypothesis, CL3 cofractionated with the lipid raft
markers, caveolin-2 and flotillin-1, in the Triton X-100-
insoluble low-density membrane fractions (Figure 2A).
We next directly visualized raft-inserted CL3 localization
in cultured neurons treated with 0.1% Triton X-100, asany residual GFP signal should then be indicative of the
presence of CL3 in detergent-resistant membrane micro-
domains. In keeping with this, a sizable detergent nonex-
tractable pool of GFP-CL3 was present in the perinuclear
Golgi and proximal dendrites in developing hippocampal
neurons (see Figure S1A in the Supplemental Data avail-
able with this article online, -GODZ arrow and arrowhead;
and Figure S1B), and this pool was further increased by
coexpression of GODZ (Figure S1A, +GODZ arrow and
arrowheads). In immature cortical neurons, a large major-
ity of the CL3 signal that was resistant to detergent treat-
ment was present both in the intracellular perinuclear
Golgi-like membranes and in the minor processes (i.e.,
dendrites) (Figure 2B, upper panel, see line scan in the
inset for CL3 signal in the dendrites). Importantly, this
detergent-resistant pool of CL3 was almost completely
lost when neurons were treated with zaragozic acid, anNeuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc. 757
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Multimeric Complex Formation of CL3
in Cortical Neurons
(A) Wild-type GFP-CL3 (WT) expressed in
cortical neurons using a synapsin I promoter-
driven lentivirus was recovered in the lipid raft
fraction (lanes 4–5), as confirmed by the
enrichment of raft marker proteins flotillin-1
and caveolin-2 (Cav-2). Fractions 1–4, 5%
sucrose; 5–12, 35%sucrose; 13, 50%sucrose.
(B) A sizable portion of total GFP-CL3 fluores-
cence was recovered after detergent treat-
ment as detergent-resistant GFP-CL3, which
was localized in a punctate manner in 2 DIV
cortical neurons along the dendrites as well
as at the perinuclear region. Dendrites were
unambiguously identified as processes of
limited length (much shorter than the axon
exceeding 100 mm). Line scans of pixel fluores-
cence, carried out within a chosen field of
a 15 mm dendritic segment (in insets 1 and 2)
by horizontally tracking the clusters of GFP-
CL3, illustrate the spotty presence of raft-
inserted CL3 along the dendrites (right panels).
Treatment with 100 mM zaragozic acid
abolished the dendritic detergent-resistant
patches and flattened the line scan profile.
Scale bar, 10 mm.
(C) CL3 forms a multimeric complex in cortical
neurons. Wild-type CL3 tagged with either HA-
tag (HA-CL3) or GFP (GFP-CL3) were coex-
pressed in cortical neurons by nucleofection
and coimmunoprecipitated using an anti-GFP
antibody. In, input; IP, immunoprecipitates.inhibitor of squalene synthase that efficiently depletes
membrane cholesterol (Figure 2B, lower panel). These
results indicated that CL3 was a genuine component of
dendritic lipid rafts and that raft insertion was likely
regulated by CL3 prenylation and palmitoylation.
Does CL3 actually share some of the properties known
for dendritic raft signaling molecules? A number of raft
proteins were previously reported to homo-oligomerize
into a multimeric protein complex via lipidification (Zacha-
rias et al., 2002; Huang and El-Husseini, 2005). Indeed,
HA-tagged WT CL3 coimmunoprecipitated with GFP-CL3
(Figure 2C) in cortical neurons. Furthermore, a significant
fluorescence energy transfer (FRET) was detected
between coexpressed CFP-CL3 and YFP-CL3 in live
hippocampal neurons, indicative of their genuine molecu-
lar proximity in a complex (Figure S2A). Interestingly, Lyn,
a well known raft-enrichedmolecule, colocalized with CL3
in live-untreated, but not in detergent-treated, neurons758 Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc.(Figure S2B). In contrast, the distribution of GluR1, a
dendritic protein that is targeted to lipid rafts by palmitoy-
lation (Suzuki et al., 2001; Hering et al. 2003; Hayashi et al.
2005), partially overlapped with CL3 even in detergent-
treated neurons (Figure S2C).
CL3 Promotes Dendritogenesis in Cortical Neurons
From previous studies (Takemoto-Kimura et al., 2003;
Wayman et al., 2004), it has been speculated that the
CaMKK-CaMKI pathway might play a role in the control
of neuronal morphology during development. In situ
hybridization of embryonic day 17.5 (E17.5) tissues
revealed a strong expression of CL3 transcript in the fore-
brain (Figures 3A and 3B) and in particular in the cortical
plate of the cerebral cortex (Figures 3C and 3D). To test
whether CL3 was involved in neuronal morphogenesis
during this period, either GFP or GFP-CL3 cDNAs were
Neuron
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dissociation, and the morphology of the neurons was
examined 48 hr later, a time point when the majority of
neurons under our culture conditions developed well-
discernable dendrites and one axon. In control GFP-
expressing neurons, little GFP fluorescence overlapped
with a Golgi membrane marker, GM130 (Figures 3E and
3F, arrow). In GFP-CL3-overexpressing cortical neurons,
however, GFP fluorescence colocalized with GM130 (Fig-
ures 3G and 3H, arrow) and also showed discrete enrich-
ment within several dendritic processes (Figures 3G and
3H, arrowhead). Compared to GFP-expressing control
neurons (Figure 3I), GFP-CL3-overexpressing neurons
appeared to exhibit unaltered axonal extension and
branching, while in contrast, increased dendritic growth
was found at and in the very vicinity of the soma
(Figure 3L). In keeping with this finding, coexpression of
mCherry-actin with GFP-CL3 (Figures 3M and 3N), but
not with GFP (Figures 3J and 3K), revealed an augmenta-
tion of actin-enriched tips at the growing ends (Figures 3M
and 3N, arrows) of the nascent processes extending out
from the soma, consistent with activation of an actin
cytoskeletal remodeling process. To quantify the morpho-
logical changes associated with CL3 overexpression,
morphometric analyses were performed on the dendrites
of GFP-CL3-expressing cortical neurons in a blind fash-
ion. We found that total dendritic length, and in particular
the length of the longest dendrite, was most strikingly
increased by CL3 overexpression, while the change in
branch-tip number remained small and not significant
(Figure 3O). CL3-dependent promotion of dendritic
growth was detected equally over the whole range of
length of primary dendrites (Figure 3P), suggesting that
the CL3 effect was unlikely to be restricted to just a
subgroup of dendrites, but rather promoted a key com-
mon step in early dendritic formation. This CL3-induced
effect was not seen with a kinase-inactive K52A mutant
(data not shown). Together, these sets of evidence
suggested the possibility that CL3 may be involved in
early stages of dendritogenesis in developing cortical
neurons.
A Required Role of CL3 in Dendritogenesis
but Not in Axonogenesis
To critically test this possibility, we next examined the
neuronal morphology in neurons where CL3 expression
was strongly attenuated byRNA interference, using a short
hairpin-type pSUPER vector that also coexpressed a PGK
promoter-driven EGFP or mRFP1 gene cassette for
morphological tracing. The knockdown efficiency and
specificity of the shCL3 vector was prominent enough
such that even an overexpressed GFP-CL3 became
barely detectable 48 hr after transfection, while the control
mRFP1 expression level remained unchanged (Figure 4A).
This shCL3 vector was introduced into embryonic cortical
neurons by electroporation, and formation of dendrites
and axons was studied 48 hr later. While the cortical
neurons showed 5–6 dendritic processes in controlexperiments, shCL3-treated neurons revealed a notable
impairment in the number and total length of MAP2-
positive dendrites (Figure 4B, arrows). In striking contrast,
formation of Tau-1-positive axons was largely spared
(Figure 4B, arrowheads). Quantitative morphometric
analyses on dendritic or axonal arborizations confirmed
that the impairment in shCL3-transfected neurons was
actually confined to a selective decline in total dendritic
length and in total tip number and did not affect either
axonal outgrowth or branching (Figures 4C and 4D). The
reduction in dendritic growth was observed throughout
the whole range of dendrite length (Figure S3). The striking
specificity in dendritic phenotype was also sustained even
in shCL3-transfected neurons that were plated following
an extensive period (48 hr) of suspension culture that
allowed them to maximize the effect of knockdown prior
to plating (Figure S4). Knockdown of either CaMKIIa or
CaMKIV revealed no phenotype, at least during the very
early dendritogenic period that we examined (Figure S5).
Taken together, knockdown of CL3 did not interfere with
the process of axon specification or axonogenesis, but
rather suppressed a subsequent process that was
required for dendritogenesis. We next asked whether
CL3’s kinase activation was a genuine requirement. The
abnormality in dendritogenesis could be rescued by addi-
tional expression of an shCL3-resistant WT (kinase-active)
CL3, but not by that of an shCL3-resistant K52A (kinase-
inactive) CL3, demonstrating the absolute necessity of
CL3 kinase activity during dendritogenesis (Figure 4E).
Consistently, early dendritogenesis, but not axonogene-
sis, was also impaired in cultured cortical neurons
obtained from CL3 null mice (Figure 4F).
In 9 DIV hippocampal neurons, CL3 knockdown dimin-
ished total dendritic length and primary dendrite number
(Figure S6) and induced an altered Golgi morphology
(Figure S7), which was somewhat reminiscent of Golgi
vesiculation associated with impaired dendritic polarity
(Horton et al., 2005).
A Required Role for CL3 in BDNF-Stimulated
Dendritic Growth
We then asked what calcium mobilization might contrib-
ute to CL3-dependent stimulation of dendrite develop-
ment. Brain-derived neurotrophic factor (BDNF) was
previously shown to strongly promote dendrite growth
and trigger an intracellular calcium rise (e.g., Huang and
Reichardt, 2003, for a review). Consistent with published
literature, bath application of BDNF induced a slow but
clear increase in intracellular Ca2+ concentration in the
cultured cortical neurons used in our study (Figures 5A–
5C). Latencies of onset and oscillatory amplitudes/
frequencies varied from neuron to neuron (Figures 5B
and 5C). Continuous treatment of cortical neurons with
BDNF significantly promoted dendritic growth (Figure 5D,
p < 0.05, ANOVA with post hoc Tukey-Kramer test). In
the presence of a global blocker of CaM kinase
activation, KN-93, both constitutive and BDNF-stimulated
components of dendritic growth were strongly inhibitedNeuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc. 759
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Regulation of Dendritogenesis via CLICK-III/CaMKIgFigure 3. Expression of CL3 in the Developing Cortex and Regulation of Dendritic Morphogenesis in Cultured Cortical Neurons
(A–D) In situ hybridization of mouse embryonic (E17.5) tissue using an antisense (AS) riboprobe revealed an intense signal of CL3 transcript in the
developing forebrain. The boxed area of a macroscopic image in (A) is shown at higher magnification (C): (left) hybridized DIG signal only; (right)
full-color image (DIG signal in blue-violet + nuclear counterstaining in red). The control sense probe detected little signal (B and D). Asterisk, pia mater;
MZ, marginal zone; CP, cortical plate.
(E–H) Membrane localization of CL3 in embryonic cortical cultures. GFP-CL3 distribution detected by anti-GFP immunostaining (G and H)
showed colocalization with a Golgi marker, GM130 ([G and H], arrows). GFP-CL3 signals were also enriched within tips of fine dendritic processes
([G and H], arrowheads). Note that the GFP signals in control neurons were separated from the red GM130 immunofluorescence (E and F). Single
representative confocal sections are shown.
(I–N) Overexpression of GFP-CL3 facilitated formation of actin-rich thin processes from dendrites and soma. Low-magnification image showed GFP-
CL3 signals were distributed both in the nascent dendrites and in the axon ([L], arrow and arrowhead, respectively). In GFP-CL3-expressing neurons,
a larger number of thin processes reminiscent of fine dendrites and/or filopodia were present at dendrites and soma ([L andM], arrows), as compared
with GFP-expressing neurons (I and J), but not at the axon ([L], arrowheads). These numerous processes contained abundant amounts of b-actin, as
shown by enrichment of mCherry-actin (arrows in [N]).760 Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc.
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Regulation of Dendritogenesis via CLICK-III/CaMKIgFigure 4. CL3 Loss-of-Function in
Embryonic Cortical Neurons Elicits
a Specific Impairment in Dendrite
Morphogenesis
(A) Efficient downregulation of exogenous
GFP-CL3 was achieved by a CL3-targeted
shRNA vector (pSUPER-shCL3), but not by
a control vector (pSUPER-shNega), in embry-
onic cortical neurons. The mRFP1 expression,
which was driven by a dual promoter in
a pSUPER +mRFP1 vector cassette, remained
unchanged.
(B)A representativeconfocal imageofanshCL3/
GFP-expressing neuron (pSUPER-shCL3)
showing impaired dendritogenesis. In this ex-
ample, an shCL3-expressiong neuron had
only a single remaining dendrite (an arrow in
the inset), while an shNega-transfected neuron
carried 5–6 dendrites (arrows in the inset). On
the other hand, no change in axonal morphol-
ogy was detected (arrowheads). Tau-1 and
MAP2 were used to identify axons and den-
drites, respectively.
(C) Monochrome diagrams of representative
shNega- or shCL3-expressing neurons. The
longest process (axon) was unchanged, while
the morphology of shorter dendrites near the
cell soma was much simplified in shCL3-
transfected neurons.
(D) Quantification of morphometric parameters
in CL3-knockdown neurons. To quantify, the
total length and the dendritic branch tip number
were calculated over the dendritic or the axonal
arborizations for all branchesexceeding 7mmin
length. In shCL3-expressing neurons, both
parameters were significantly reduced in the
dendrites. On the other hand, neither axonal
length nor axonal branch tip number were sig-
nificantly altered. Number of neurons: shNega,
n = 78; shCL3, n = 53. ***p < 0.001; n.s., not sig-
nificant (p > 0.05) (t test).
(E) Requirement for CL3 kinase activity to
rescue shCL3-mediated impairment in dendri-
togenesis. Introduction of an shCL3-resistant
silent mutant of wild-type GFP-CL3 (WTres)
successfully rescued the dendritic phenotype
elicited by shCL3 on both morphometric
parameters. The shCL3-resistant kinase-
inactive GFP-CL3 (K52Ares) was unable to
rescue the shCL3 phenotype. Number of neurons: shNega, n = 37; shCL3 + mock, n = 35; shCL3 + WTres, n = 41; shCL3 + K52Ares, n = 33. **p <
0.01; ***p < 0.001; n.s., not significant (p > 0.05) (ANOVA with post hoc Tukey-Kramer test).
(F) Dendritogenesis, but not axonogenesis, is specifically impaired in cultured cortical neurons from CL3-KO mice. WT, n = 20; CL3-KO, n = 20.
*p < 0.05; **p < 0.01; n.s., not significant (p > 0.05) (t test). Scale bars, 50 mm (A–C) and 20 mm ([B], inset).(Figure 5D). Because KN-93 suppressed dendritic growth
to a similar extent under either constitutive or BDNF-
stimulated conditions, this raised the possibility of a
common involvement of a KN-93-sensitive kinase (Fig-
ure 5D). To specifically test this idea, we employed RNAiand measured the degree of suppression of dendritic
growth in the absence or presence of BDNF application
and found that indeed CL3 knockdown completely
phenocopied the effect of KN-93 on dendrites and oc-
cluded BDNF-stimulated dendritic growth (Figure 5E).(O) Facilitation of dendritic outgrowth by CL3 overexpression. Total length, branch tip number, and longest dendrite length are shown. Number of
neurons: GFP, n = 30; GFP-CL3, n = 30. ***p < 0.001; n.s., not significant (p > 0.05) (t test).
(P) Cumulative probability analysis shows a significant extension of primary dendrites in GFP-CL3-expressing neurons (**p < 0.01, Kolmogorov-
Smirnov test). Numbers of examined dendrites: GFP, n = 258 (from 50 neurons); GFP-CL3, n = 321 (from 50 neurons).
Scale bars, 300 mm (A and B); 50 mm (C and D); 10 mm (E–H); 20 mm (I–N).Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc. 761
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ing an shCL3-resistant wild-type, but not a membrane
anchoring-defective CL3 mutant (Figure 5F). Thus, signal-
ing via membrane-anchored CL3may play a critical role in
BDNF-mediated cortical dendritogenesis during early
development.
A Lipid-Raft-Delineated CL3-STEF-Rac
Pathway Contributes to the Development
of Cortical Dendrites
What are the signaling components that underlie lipidified
CL3-mediated dendritic growth? Taking advantage of our
finding that CL3 overexpression was accompanied by
a sizable increase in the length of primary dendrites (Fig-
ures 3O, 3P, and 6A), and in particular its longest dendrite
(Figure 3O, right panel; Figure 6B), we next tested the pos-
sible contribution of small GTPases downstream of CL3.
Coexpression of a dominant-negative Rac abolished the
effect of CL3 overexpression (Figures 6A and 6B), and
this effect was seen throughout the observed range of
primary dendrite length (Figure 6C), supporting the idea
that Rac mediated CL3-stimulated dendritic growth. Con-
sistently, we found that CL3 knockdown downregulated
Rac activity (Figure 6D). Furthermore, overexpression of
a dominant interfering fragment (PHnTSS) of STEF, a spe-
cific RacGEF previously implicated in cortical migration
and neurite outgrowth (Kawauchi et al., 2003; Matsuo
et al., 2002), also potently repressed the CL3 effect (Fig-
ures 6A and 6B); however, this effect was less pronounced
in dendriteswith shorter lengths (<20 mm) (Figure 6C). Both
STEF and Rac were detected in the Triton X-100-insoluble
low-density membrane fractions enriched for flotillin-1 but
devoid of transferrin receptors (Figure 6E), consistent with
the presence of a raft-delineated CL3-STEF-Rac pathway.
In keeping with this, sustained Rac activity significantly at-
tenuated the impairment in dendrite development ob-
served in CL3-diminished neurons (Figures 6F and 6G).
If raft localization of CL3 was critical for CL3-dependent
dendritogenesis, a raft depletion by pharmacological
manipulation or a removal of CL3 from rafts by mutation
of its palmitoylation sites should significantly perturb
dendrite formation and growth. To test this, we pretreated
cortical neurons with either mevastatin, an HMG-CoA
reductase inhibitor, to deplete membrane cholesterol,
and/or with fumonisin B1, an inhibitor of sphingolipid
synthesis. Treatment with either mevastatin or, to a lesser
extent, with fumonisin B1 reduced dendritogenesis (Fig-
ures 7A and 7B). A combination of both had no further
additive effect (Figures 7A and 7B). As mevastatin was
expected to interfere not only with cholesterol synthesis
alone but also with protein prenylation, we also examined
the effect of zaragozic acid, an inhibitor of squalene syn-
thase, which would disrupt cholesterol synthesis while
sparing mevalonate production. Zaragozic acid treatment
diminished dendrite formation to a degree similar to the
effect seen with mevastatin; a combination of both did
not produce a further incremental effect (Figures 7A and
7B). Interestingly, raft depletion by treatment with zara-762 Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc.gozic acid abolished the dendritogenic action of overex-
pressed CL3 (Figure 7C). Together, these results further
supported the idea that the presence of intact lipid rafts
was critical for CL3 to exhibit its dendritic effect.
In keeping with this, a palmitoylation-site-deficient 4CS
mutant of CL3, which was made resistant to shCL3 RNAi
vector, was unable to rescue the dendritic effect of CL3
knockdown in cortical neurons (Figure S4C). Intriguingly,
in hippocampal neurons, the inaccessibility of 4CSmutant
protein toward detergent-resistant raft membranes in
CL3-knockdown cells (Figure S8A) was accompanied
with the appearance of exuberant thin filopodial pro-
cesses from the soma (Figure S8B, arrows). These results
are consistent with a role of palmitoylation in targeting,
and perhaps restricting, CL3 expression to its appropriate
sites of cellular actions. Taken together, CL3 palmitoyla-
tionmay be a useful means to restrict STEF-Rac activation
to microdomains in the vicinity of dendritic rafts during
early dendritogenesis.
DISCUSSION
Identification of CL3/CaMKIg as a Privileged Kinase
Involved in the Regulation of Dendritic
Cytoarchitecture during Early CNS Development
Previous analyses have established the necessity
of CaMKII, a predominant form of CaM kinase, as
molecular switch required for neuroplasticity in the hippo-
campus, the barrel cortex, and the visual cortex (Lisman
et al., 2002; Fox and Wong, 2005). Furthermore, the role
of CaMKII isoforms in several forms of dendritic develop-
ment was extensively studied, though the exact effect on
dendrite morphogenesis has remained rather controver-
sial. CaMKIIa was shown to contribute to dendritic out-
growth in cerebellar granule neurons (Gaudilliere et al.,
2004), and CaMKIIb but not CaMKIIa regulated the move-
ment and branching of filopodia and fine dendrites in rat
hippocampal neurons (Fink et al., 2003). In contrast, in
Xenopus retinotectal neurons, CaMKII was reported to
limit dendritic outgrowth and to stabilize dendritic arbori-
zation in vivo (Wu and Cline, 1998).
In contrast to CaMKII, which is one of most abundant
proteins expressed in the postsynaptic density (PSD)
(Kennedy, 2000), CaMKIV in the nucleus plays a critical
role in mediating Ca2+-regulated transcription via a
CREB/CBP pathway, which is necessary for the formation
of long-term synaptic plasticity and long-term memory
(Silva et al., 1998; Bito and Takemoto-Kimura, 2003), as
well as activity-dependent dendritic elongation (Redmond
et al., 2002). In turn, a cytosolic CaMKI activity has been
shown to participate in the gating of an ERK/MAP-kinase-
dependent form of LTP (Schmitt et al., 2005). Neurite out-
growth was also reported to be regulated by a presumably
cytosolic CaMKK-CaMKI/IV pathway: indeed, a constitu-
tively active CaMKIV was suggested to enhance dendritic
growth via stabilization of b-catenin (Yu and Malenka,
2003), while a CaMKK inhibitory drug, STO-609, or puta-
tive dominant-negative constructs specifically blocking
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Regulation of Dendritogenesis via CLICK-III/CaMKIgFigure 5. Requirement of CL3 for BDNF-Stimulated Dendrititogenesis
(A) BDNF-induced calcium transients in developing cultured neurons. A representative image of cortical neurons during a typical calcium rise after
BDNF bath application is shown in (A). Embryonic cortical neurons (1 DIV) were loaded with a calcium indicator, Fluo-4AM, and calcium responses
were measured by time-lapse imaging. A green fluorescence image was overlaid on a DIC image. Colored boxes indicate the location of cells shown
in (B). Scale bar, 50 mm.
(B) Representative calcium responses in individual cells after BDNF administration. Three different types of calcium responses were revealed. The
majority of cells showed a large transient response followed by smaller repetitive responses (blue), whereas some showed oscillation (yellow) or
chronic increases from the baseline (red).
(C) Averaged calcium responses after BDNF administration. An averaged response from 70 cells in a microscopic field is shown.
(D) Cortical neurons were transfected with a morphological tracer, mCherry, and stimulated with BDNF from 6 hr to 48 hr after plating, in the presence
or absence of KN-93, a general CaM kinase inhibitor. BDNF treatment maximized dendritogenesis, and this BDNF-stimulated increment was
occluded in neurons treated with KN-93. Numbers of neurons: vehicle + DMSO, n = 25; vehicle + KN-93, n = 44; BDNF + DMSO, n = 38; BDNF +
KN-93, n = 32.
(E) Quantification of dendritogenesis in BDNF-stimulated CL3-knockdown neurons. CL3 knockdown severely inhibited dendritogenesis induced by
BDNF administration, to an extent similar to that obtained with KN-93. Numbers of neurons: vehicle + shNega, n = 40; vehicle + shCL3, n = 41; BDNF +
shNega, n = 40; BDNF + shCL3, n = 40.
(F) Suppression by CL3 knockdown of BDNF-stimulated dendritogenesis can be rescued by coexpression of an shRNA-resistant wild-type CL3
(WTres), but not by a nonlipidified mutant CL3 (C474Sres). Numbers of neurons: shNega + mock, n = 52; shCL3 + mock, n = 57; shCL3 + WTres,
n = 57; shCL3 + C474Sres, n = 55.
***p < 0.001; n.s., not significant (ANOVA with post hoc Tukey-Kramer test).either CaMKK or cytosolic CaMKI/CaMKIV (but not nu-
clear CaMKIV) activities prevented axonal extension and
growth cone dynamics as well as neurite extension
(Schmitt et al., 2004; Wayman et al., 2004).
Taken together, multiple CaM kinase pathways that are
segregated in distinct subcellular compartments may
regulate several critical steps converging onto dendrite
elongation and maturation. This prompted us to investi-
gate the particular role of CL3/CaMKIg (Takemoto-
Kimura et al., 2003; Nishimura et al., 2003), a membrane-
anchored form of CaMKI, which was highly expressed in
the cortical plate neurons of the mouse embryo (this
study). Intriguingly, we found a specific impairment in
the number and total lengths of dendrites in CL3 knock-down and CL3 null neurons (Figure 4 and Figure S3),
while axonal morphology was not significantly distinct
from controls. Knockdown of CL3 prior to plating of
neurons strengthened this suppressive effect on the
dendrites while still sparing the axons (Figure S4). Taken
together, our data suggested a prominent role of CL3
during the early stages of dendritogenesis that pre-
sumably followed completion of the axon/dendrite
specification.
While this paper was under review, an independent
study reported that CL3/CaMKIg may regulate activity-
dependent dendritic growth at an even later stage of
development in hippocampal neurons (Wayman et al.,
2006; see also Figures S6 and S7 of this study).Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc. 763
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Regulation of Dendritogenesis via CLICK-III/CaMKIgFigure 6. A Critical Role for RacGEF STEF and Rac in Mediating CL3-Induced Dendritic Outgrowth
(A) Cortical neurons were cotransfected with GFP-CL3 and either dominant-negative Rac1 (RacDN) or dominant-interfering fragment of STEF
(STEFDN) together with a morphometric tracer, mRFP1. Examples for dendrites (arrows) and axons (arrowheads) are shown. Scale bar, 20 mm.
(B) Quantification of longest dendrite. Number of neurons: GFP + mock, n = 51; GFP-CL3 + mock, n = 50; GFP-CL3 + RacDN, n = 57; GFP-CL3 +
STEFDN, n = 60. ***p < 0.001 (ANOVA with post hoc Tukey-Kramer test).
(C) Cumulative probability analysis of the length of primary dendrites showed that inhibition of STEF and Rac activity suppressed the extension of
primary dendrites induced in GFP-CL3-expressing neurons. Number of examined dendrites (neurons): GFP, n = 324 (from 51 neurons); GFP-CL3,
n = 332 (from 50 neurons); GFP-CL3 + RacDN, n = 328 (from 57 neurons); GFP-CL3 + STEFDN, n = 378 (from 60 neurons). *p < 0.05; **p < 0.01;
***p < 0.001 (Kolmogorov-Smirnov test).764 Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc.
Neuron
Regulation of Dendritogenesis via CLICK-III/CaMKIgFigure 7. Raft Depletion Abolishes CL3-Mediated Dendrite Outgrowth
(A) Cortical neurons were transfected with a morphological tracer, mCherry, and cultured in the presence of various combinations of raft-depleting
agents from 6 hr to 48 hr after plating. Disruption of cholesterol/sphingolipid synthesis strongly inhibited formation and outgrowth of the dendritic
processes around the soma. Scale bar, 50 mm.
(B) Ensemble average of experiments shown in (A). DMSO, n = 10; 10 mM mevastatin, n = 15; 10 mM fumonisin B1, n = 15; 10 mM fumonisin B1 and
10 mMmevastatin, n = 15; 100 mM zaragozic acid, n = 15; 100 mM zaragozic acid and 10 mMmevastatin, n = 15. ***p < 0.001 (ANOVA with post hoc
Tukey-Kramer test).
(C) Raft depletion using zaragozic acid abolished the increase of dendritogenesis induced by CL3 overexpression. A significant CL3-mediated
increase in dendritic growth was shown in the DMSO control, but this significant increase was abolished by raft depletion in the presence of zaragozic
acid (two-way ANOVA, CL3 effect, F1,65 = 8.65, p = 0.0045; drug effect, F1,65 = 51.95, p < 0.0001; CL3 3 drug, F1,65 = 8.38, p = 0.0052). ***p < 0.001
(post hoc Bonferroni test). DMSO, n = 15 (CL3), n = 24 (+CL3), 100 mM zaragozic acid, n = 15 (CL3), n = 15 (+CL3).Control of CL3 Targeting to Lipid Microdomains
by a Kinase-Activity-Regulated Dual
Lipidification Mechanism
In polarized neural cells, covalently attached lipid modifi-
cation of proteins is important for membrane targetingand expression of proper function in the vicinity of special-
ized membrane compartments. Largely based on quanti-
tative work on Ras and PSD-95, a palmitoylation/depalmi-
toylation cycle has been previously suggested to play
a crucial regulatory role in determining the proper(D) The amount of GTP-bound active Rac1 was measured by a Pak1-PBD pulldown assay using cortical neurons transfected with shNega or shCL3
vector. The amount of active Rac1 was reduced by CL3 knockdown.
(E) Presence of Rac1 and STEF immunoreactivities in lipid raft fractions of cortical neurons. For STEF detection, a pooled and concentrated raft
fraction was used. Transferrin receptor was used as a non-raft membrane marker.
(F) Representative images of shCL3/mRFP1-expressing neurons coexpressing constitutively active GFP-Rac1 (+V12Rac1) or GFP (+mock). Expres-
sion of constitutively-active GFP-Rac1 (+V12Rac1) restored appearance of multiple dendrites (arrows) in shCL3-expressing neurons, while expres-
sion of GFP alone did not. Scale bar, 50 mm.
(G) Quantification of dendritic morphogenesis confirmed that constitutively active GFP-Rac1 attenuated the specific impairment of dendritic
morphology induced by shCL3 transfection. Number of neurons: shNega + mock, n = 22; shCL3 + mock, n = 47; shCL3 + V12Rac1, n = 49. *p <
0.05; **p < 0.01; ***p < 0.001 (ANOVA with post hoc Tukey-Kramer test).Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc. 765
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Regulation of Dendritogenesis via CLICK-III/CaMKIgtrafficking and function of palmitoylated signaling proteins
(Huang and El-Husseini, 2005). Dynamic regulation of pal-
mitoylation was already shown for a large number of syn-
aptic constituents such as AMPA-receptor subunits (Hay-
ashi et al., 2005), GABAR g-subunits (Keller et al., 2004),
and GRIP/ABP (DeSouza et al., 2002), indicating a critical
role for neuronal PAT in synaptic maturation and mainte-
nance. However, a direct involvement of protein palmitoy-
lation in early stages of neuronal morphogenesis has not
been examined.
In this work, we demonstrated that the C-terminal end
of CL3 was covalently modified in a sequential manner
by prenylation and by palmitoylation. A dually lipidified
CL3 was generated in a kinase-activity-dependent man-
ner, in part via the PAT GODZ (Uemura et al., 2002),
resulting in an efficient enrichment into dendritic-raft-like
lipid microdomains.
We then found that dually lipidified CL3 was likely to be
partitioned and targeted to close proximity of dendritic
lipid microdomains. Consistently, CL3 showed self-
association (Figure 2C and Figure S2A), a property that
is not unusual for palmitoylated or dually lipidified proteins
(Zacharias et al., 2002). However, we failed to detect any
Ca2+/CaM-independent kinase activity of CL3, even under
conditions where CL3multimerization was present. This is
distinct from the property of CaMKII, in which dodecame-
rization was shown to promote a Ca2+/CaM-independent
kinase activity that outlasted the duration of the incoming
Ca2+ mobilization through an autophosphorylation mech-
anism. We thus speculate that oligomerization, if any, of
prenyl-/palmitoyl-CL3 may have roles other than the
generation of an autonomous kinase activity, such as
sustaining a high degree of molecular proximity and con-
centration that favors signal amplification and increases
the specificity and efficiency of coupling to downstream
signaling events.
A BDNF-CL3-Rac Pathway May Underlie Excitation-
Morphogenesis Coupling during Early Cortical
Dendritogenesis
Previously, neuronal activity has been shown to promote
initiation of dendrite formation via small GTPases such
as Rac and Cdc42 (Luo, 2002; Van Aelst and Cline,
2004). To date, however, knowledge about how neuronal
activity regulates these small GTPases is still limited.
The strongest evidence in favor of activity-induced den-
dritic arborization so far involved several Ca2+-regulated
transcriptional factor such as CREB, NeuroD, and CREST
(Gaudilliere et al., 2004; Konur and Ghosh, 2005), though
the cellular mechanisms linking nuclear events and neuro-
nal morphogenesis remained as yet largely undetermined.
Here we found that a membrane-bound CaM kinase, CL3/
CaMKIg, may possibly act downstream of BDNF and Ca2+
signals to promote dendritic cytoskeletal remodeling via
the small GTPase Rac, especially during early stages of
dendritic development. Furthermore, we provided several
lines of evidence that collectively indicated that CL3-766 Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc.STEF-Rac signaling triggered at or in the vicinity of lipid
rafts may play a critical role.
Could lipid rafts, also known as sphingolipid- and
cholesterol-rich membrane microdomains, be distributed
in an asymmetric fashion such that some of these may
influence dendrite targeting of signaling proteins such as
CL3? In support for such an idea, depletion of cellular
cholesterol/sphingolipid content in cultured neurons
revealed an important role for cholesterol (Fan et al.,
2002) or sphingolipids (Schwarz and Futerman, 1998;
Pelled et al., 2003) in dendritic growth and spine mainte-
nance (Hering et al., 2003). In addition, no responsiveness
to glutamate application was reported in neonatal cortical
neurons of a mutant mouse deficient in cholesterol
biosynthesis, despite a normal amount of GluR and
NMDAR subunit expression, indicating a possible defect
in membrane insertion of dendritic glutamate receptors
(Wassif et al., 2001). A distinct kind of raft-mediated
asymmetry may play a role in axonal fate specification
(Da Silva et al., 2005).
If raft formation was coupled with the creation of a
polarized asymmetry of signaling molecule distribution,
how could this possibly underlie a morphogenetic
response, especially downstream of BDNF? Recruit-
ment of activated TrkB to lipid rafts (Suzuki et al.,
2004) could evidently contribute to efficient coupling to
raft-targeted CL3 downstream of BDNF. In neurons,
fractionation experiments during development have
also previously revealed a privileged association of
Rac with rafts, but not of RhoA or Cdc42 (Kumanogoh
et al., 2001; see also Figure 6E). We additionally found
that a portion of STEF was clearly present in the raft
fractions as well (Figure 6E). As the fragment encom-
passing the PHnTSS domain of STEF (PHnTSS) has
been shown to act as a specific dominant-negative
form for both STEF and Tiam1 (Matsuo et al., 2002), it
remains possible that there may also be an additional
contribution of Tiam1, a known substrate for CaMK
activity (Tolias et al., 2005).
Taken together, dual lipidification of CL3 may be an
efficient mechanism not only to target it into rafts and to
limit its protein diffusion parallel to the lipid bilayer, but
also to generate a membrane-delimited area of Rac acti-
vation within segregated dendritic lipid microdomains at
the vicinity of Ca2+-mobilization events. Further studies
are needed to substantiate such a hypothesis.
In conclusion, we here uncovered a novel role for CL3/
CaMKIg in the regulation of Rac-dependent dendritic
cytoskeletal reorganization, and we found evidence for
CL3 in mediating BDNF-stimulated dendritic growth.
Through a dual and sequential lipidification mechanism,
the unique C-terminal region of CL3 was covalently lipid-
modified in a kinase-activity-dependent manner, leading
to a privileged partition of membrane-anchored CL3 into
dendritic-raft-like lipid microdomains. This membrane-
sorting mechanism, unprecedented for a neuronal Ser/
Thr kinase, in turn may efficiently localize Rac activity
and thereby regulate dendritogenesis. Thus, CL3 turned
Neuron
Regulation of Dendritogenesis via CLICK-III/CaMKIgout to represent a key element in the Ca2+-dependent and
lipid-raft-delineated switch that turned on activity-regu-
lated dendrite formation in developing cortical neurons.
EXPERIMENTAL PROCEDURES
Cloning and Plasmid Constructions
A detailed description of all plasmids can be found in the Supplemental
Data.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde/4% sucrose/phosphate-
buffered saline (PBS) () at room temperature for 20 min, and immu-
nostaining was carried out as described (Takemoto-Kimura et al.,
2003). Additional methods can be found in the Supplemental Data.
Western Blot Analysis
For western blot analysis, primary antibodies were as follows: rat anti-
GFP (Nacalai Tesque, Japan), rat anti-HA (Roche Diagnostics), mouse
anti-Flotillin-1, mouse anti-Caveolin-2, and anti-Rac1 (BD Transduc-
tion Laboratories). A rabbit anti-STEF antibody was as described (Mat-
suo et al., 2002). Chemiluminescence detection was performed using
HRP-conjugated anti-rat and anti-mouse IgG and ECL-Plus reagent
(Amersham Biosciences).
Metabolic Labeling and Coimmunoprecipitation
For metabolic labeling, COS-7 cells plated onto 6-well plates were
transfected with wild-type and mutant GFP-CL3 vectors using
Fugene6 reagent (Roche Diagnostics). For mevalonate labeling,
a pMev vector (ATCC), which encoded a transporter that augmented
mevalonic acid uptake, was cotransfected with GFP-CL3 for 24 hr.
Cells were pretreated with 40 mM Compactin (Wako, Japan) for 2 hr,
then incubated for 20 hr in growth medium supplemented with
40 mM Compactin and 0.1 mCi/ml of [3H]-mevalonolactone (Perki-
nElmer or ARC). Palmitate labeling was initiated 48 hr after transfection
by pretreating cells with serum-free medium (DMEM with 1% fatty-
acid-free bovine serum albumin [Sigma]) for 1 hr, and then incubating
for an additional 3 hr in the serum-free medium supplemented with 0.4
mCi/ml of [3H]-palmitic acid (PerkinElmer). After metabolic labeling,
cells were washed twice in ice-cold phosphate-buffered saline (PBS)
() and lysed in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 100
mM NaCl, 2 mM MgCl2, 10% glycerol, 1% Triton X-100, and a
Complete protease inhibitor cocktail (Roche Diagnostics). Lysates
were immunoprecipitated using a rabbit anti-GFP polyclonal antibody
(Molecular Probes) and Protein-A-Sepharose (Amersham Biosci-
ences). Immunoprecipitates were washed three times in lysis buffer
and boiled in 43 Laemmli buffer containing 5 mM DTT for 3 min and
were subjected to SDS-PAGE. Incorporated mevalonolactone and
palmitic acid were digitally detected using a BAS-5000 bioimage
analyzer and quantified using Multi Gauge software (Fujifilm, Japan).
In coimmunoprecipitation assays, cortical neurons were transfected
with GFP-CL3 and HA-CL3 vectors by electroporation using Nucleo-
fector (Amaxa Biosystems) and plated onto poly-D-Lysine-coated 6
cm dishes at the density of 4 3 105/cm2 and then harvested at 2
DIV. Immunoprecipitation was performed as described above.
Lentivirus Production, Infection, and Lipid Raft Fractionation
A 536 bp synapsin I promoter was isolated by PCR from rat genomic
DNA and inserted into CS-CA-MCS (Miyoshi et al., 1998) to replace
the original chicken actin promoter. EGFP-CL3 fragment was further
inserted and cotransfected with pCAG-HIVgp and pCMV-VSV-G-
RSV-Rev into HEK293T cells using Fugene6 reagent to generate
a self-inactivating lentivirus vector. All original lentivirus vectors were
provided by Dr. Hiroyuki Miyoshi (RIKEN-BRC, Japan). Concentrated
virus solutions were obtained by ultracentrifugation at 80,000 3 g,
and virus titer was determined using HeLa cells. Cortical neurons(1 DIV) were infected with lentivirus for 5 hr at a nominal MOI of about
0.2, and after washout, maintained in Neurobasal containing 0.5 mM
Glutamax, 1 3 B27, and 25 mg/ml insulin. Under these conditions,
GFP-positive glial cells (as determined by GFAP expression) were
less than 6%. Though the nominal MOI was about 0.2, this is very likely
to be an underestimate, as it was calculated based on the induction of
trace EGFP fluorescence in heterologous cells. Lipid raft preparations
were performed 2 days after infection (3 DIV).
Lentivirus-infected cortical neurons in 10 cm dishes (3.53 105 cells/
cm2) were harvested at 3 DIV for preparation of detergent-insoluble
membrane fractions according to Suzuki et al. (2004) with minor
modifications. Thirteen fractions (1 ml each) were collected and 15 ml
of each fraction were subjected to SDS-PAGE followed by western
blot analysis. To obtain a concentrate of the raft fractions in Figure 5E,
raft fractions (fractions 4 and 5) were pooled, and a portion of it (1.4 ml)
was ultracentrifuged at 20,0003 g for 1 hr at 4C. The pellet was resus-
pended in 140 ml of Buffer A (50 mM Tris-HCl [pH 7.5], 50 mM NaCl),
and 15 ml of the final sample was subjected to SDS-PAGE and western
blot analysis.
Cell Culture Preparation and Visualization of Raft-Targeted
Proteins
COS-7 cells were maintained in Dulbecco’s modified Eagle medium
(DMEM) containing 10% heat-inactivated fetal calf serum (FCS).
Dissociated cortical cultures from embryonic day 19 Sprague-Dawley
rats were prepared as described previously for rat hippocampal
cultures (Bito et al., 1996) with minor modifications. Cortical neurons
were plated onto 12 mm poly-L-Lysine-coated coverslips at the
density of 5 3 105 cells per coverslip in a 24-well plate.
Gene targeting of CL3/CaMKIg was carried out in a C57BL/6-
derived ES cell line RENKA (Mishina and Sakimura, 2007) by insertional
mutagenesis. The exons 2 and 3 of mouse the Camk1g gene, which
contained the kinase ATP-binding site, were deleted and replaced
by a targeting construst such that the first methionine of CL3was fused
in-frame to an hCrePR-IRES-EGFP cassette that was juxtaposed to an
inverted neomycin resistance gene flanked by FRT sites. A detailed
analysis of the CL3/CaMKIg null mouse mutant will be described
elsewhere (S.T.-K., M.O., T. Takeuchi, K. Sakimura, M.M., H.O., and
H.B, unpublished data). Cortical mouse cultures were prepared from
embryonic day 17 C57BL/6J wild-type or CL3 null mice.
For visualization of in situ raft-targeted GFP-fusion proteins, rat
cortical or mouse hippocampal neurons were washed with KRH buffer
(Suzuki et al., 2004) containing 2 mM Ca2+ on ice, permeabilized with
0.1% Triton X-100/KRH(+) for 2 min on ice, washed gently, and then
fixed. Raft depletion in cortical neurons was carried out by including one
of the following drugs (10 mM mevastatin, 10 mM fumonisin B1, 10 mM
fumonisin B1 and 10 mM mevastatin, 100 mM zaragozic acid, 100 mM
zaragozic acid, and 10 mMmevastatin) in the culture medium from 6 hr
after plating onward for an additional 42 hr. mRFP1 was nucleofected
for accurate visualization of the contours of individual neurons.
In one instance, rat hippocampal neurons obtained from P0–1
Sprague-Dawley rats (Bito et al., 1996) were used to quantify FRET
between CL3 molecules (Figure S2A).
Morphometric Analysis of the CL3-Associated Phenotype
in Cultured Neurons
Dissociated cortical cultures from embryonic day 19 Sprague-Dawley
rats were prepared as described previously for rat or mouse hippo-
campal cultures (Bito et al., 1996; Furuyashiki et al. 2002) with minor
modifications. Cortical neurons were transfected immediately after
dissociation by electroporation using Nucleofector and plated onto
12 mm poly-L-Lysine-coated coverslips at the density of 53 105 cells
per coverslip (rats) or 7.5 3 105 cells per coverslip (mice) in 24-well
plates, and then fixed at 2 DIV. Presumably because of a relatively
low amount of plasmid transfer across neuronal membranes during
electroporation procedure, use of a strong CAG promoter-driven
expression cassette was needed to reliably express foreign genes.Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc. 767
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expressing various shRNA vectors and rescue constructs, we carried
out all quantitative analyses based upon immunostaining of the mor-
phometric markers, either GFP or mRFP1 (a kind gift from Dr. Roger
Y. Tsien, HHMI, UCSD). This allowed us to obtain clearer images of
neuronal contours, thus facilitating morphometric analyses. The
transfection efficiency was relatively high (about 50% in our hands
using this protocol) when examined within a day after electroporation.
Thus, we were able to improve the accuracy of visualization in all
morphometric experiments by simply mixing the transfected cells
with nontransfected cells prepared in parallel, at a ratio of 1:20 (rats)
or 1:10 (mice), before plating. Dendritic and axonal arborizations of
most transfected neurons could then be traced in total isolation while
they still formed a dense network with neighboring untransfected
neurons. Neurons expressing pSUPER-type vectors revealed negligi-
ble amounts of either cell death (0%–0.5%) as measured by TUNEL
staining (Roche Diagnostics) or dsRNA-induced interferon-like
response monitored using a muMx2 promoter-luc vector (a kind gift
from Dr. Atsushi Asano, Hokkaido University) (Alvarez et al., 2006).
In the Rac1-rescue experiments, even an intermediate-level expres-
sion of a constitutively active Rac mutant, GFP-V12Rac1, using a CAG
promoter usually resulted in an aberrant neuronal morphology, such as
exuberant lamellipodia formation at the cell soma and premature
detachment from the glass coverslip. To circumvent this problem,
GFP-V12Rac1 was introduced using a CMV promoter-based plasmid
vector, as the observed expression level was lower than that obtained
using a CAG promoter vector. A few neurons still showed an aberrant
somata size and shape and thus were excluded from analyses.
Images of neuronal morphologies were captured based on immuno-
reactivities against GFP or mRFP1, using the Olympus BX51 micros-
copy system with the 203 objective or 403 objective in the cases of
CL3-overexpression experiments to visualize fine protrusions for
cumulative probability analysis. Dendrites and axons were identified
by standard morphological criteria. As the majority of neurons, in our
cortical culture preparation, possessed only one clearly classifiable
axon and one or more dendrites, neurons with nonpyramidal morpho-
logical features (such as multiple axons or no classifiable processes)
were excluded from analyses. The total length and the dendritic branch
tip number were determined manually using NeuronJ 1.1.0 (Meijering
et al., 2004), plug-in software for ImageJ (NIH). Representative images
were acquired using the LSM 510META confocal microscope with the
403 objective. All analyses were performed by an observer blinded to
the identity of the transfected constructs.
In experiments described in Figure S4, electroporated neurons were
initially cultured as a suspension in a growth medium, without plating,
in plastic centrifuge tubes at the density of 2 3 106 cells/ml, while
neurons were allowed to form aggregation. Forty-eight hours later,
aggregated neurons were then dissociated mechanically by gentle
pipetting and plated onto 12 mm poly-L-Lysine-coated coverslips at
the density of 1 3 106 cells per coverslip. Fixation and analysis were
carried out 24 hr later.
Mouse hippocampal neurons were transfected using Lipofectamine
2000 (Invitrogen) at 7 DIV and analyzed at 9 DIV. Morphometric analy-
ses of hippocampal neurons were performed as essentially described
above for cortical neurons. Only primary dendrites were traced using
ImageJ/NeuronJ software.
In Situ Hybridization
In situ hybridization using DIG technology (Roche Diagnostics) was
performed essentially as described (Ohmae et al., 2006). For the
generation of antisense and sense cRNA probes, a 374 bp fragment
corresponding to the nucleotide position 964–1337 of CL3 was subcl-
oned into pBluescriptII KS+ vector (Stratagene).
BDNF Application and Calcium Imaging in Cortical Neurons
BDNF (generously provided by Dainippon Sumitomo Pharma, Osaka,
Japan, by courtesy of Dr. Chikao Nakayama) and/or KN-93 (Calbio-768 Neuron 54, 755–770, June 7, 2007 ª2007 Elsevier Inc.chem) were added to cells at 6 hr after plating at the final concentration
of 50 ng/ml and 10 mM, respectively. Bath application was performed
by dissolving the reagents in one-half volume of the conditioned
culture medium and by mixing this gently with the remaining half of
the original medium in the dish. No medium change was done there-
after till fixation.
Fluorescent calcium imaging was performed essentially as de-
scribed previously (Furuyashiki et al., 2002). A detailed description of
further experimental conditions can be found in the Supplemental
Data.
Rac1 Pull-Down Assays, Measurement of Fluorescence
Resonance Energy Transfer, and Quantification
of Golgi Deformation
A detailed description of experimental procedures can be found in the
Supplemental Data.
Statistical Analysis
Statistical analyses were performed using Prism 4.0 (GraphPad Soft-
ware) and JMP5.1.2 (SAS Institute). Student’s t test was used for com-
parisons of two groups. One- or two-way analysis of variance (ANOVA)
with post hoc Tukey-Kramer or Bonferroni test was used for factorial
analysis between more than three groups. The Kolmogorov-Smirnov
test was applied to verify whether the bidirectional effect of CL3
manipulation occurred throughout all dendrites or was restricted to
a subpopulation. All data are shown as mean ± standard error of
means (SEM), unless otherwise mentioned.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/54/5/755/DC1/.
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